Binocular Progressive System Boosts clariti

With several next-generation enhancements, CooperVision said the new lens is designed to provide better vision¹ and high levels of comfort^2,3 for presbyopic patients, along with an easy and successful fitting experience⁴ for optometrists.

Nearly two billion people worldwide now experience presbyopia,⁵ yet multifocal contact lenses remain significantly underutilised, representing a major missed opportunity for both patients and eye care professionals.⁶

The clariti 1day multifocal offers the widest range of prescription options across spherical, toric and multifocal lenses^†7 and is supported by proven the Binocular Progressive System technology used in MyDay multifocal,⁸ CooperVision.

the clariti 1 day multifocal allows practitioners to deliver better vision¹ and comfort using an efficient fitting approach

Michelle North, General Manager CooperVision Australia and New Zealand said that by applying the advanced lens design introduced in the MyDay multifocal,⁸ CooperVision was “giving optometrists in Australia and New Zealand an excellent product to address the growing needs of presbyopic patients”.

The clariti 1 day multifocal with CooperVision Binocular Progressive System maintains the features optometrists and wearers value about the lens,^9,10,11 while providing improved visual acuity at all distances.¹

Key enhancements include:

• CooperVision Binocular Progressive System making it easier for practitioners to fit patients with the right lens from the start¹⁰ with the widest power range of any 1-day multifocal,¹²
• Optimised Comfort Edge for good comfort, ¹³ and
• WetLoc Technology to maintain lens hydration throughout the day.¹⁴

Enhanced Fitting

Historically, multifocal contact lenses have been perceived as complex and time-consuming to fit – limiting adoption despite strong patient demand.¹⁵ CooperVision’s Binocular Progressive System¹ directly addresses these barriers, delivering a streamlined, evidence-backed fitting approach that has achieved fitting success in 98% of patients with two pairs of lenses or fewer.¹⁶

“For optometrists, the combination of a simplified fitting process and strong fitting success data makes a real difference in practice,” said Joe Tanner, Head of Professional Affairs, CooperVision ANZ. “Presbyopic patients often present with a variety of visual needs, and the clariti 1 day multifocal allows practitioners to deliver better vision¹ and comfort^2,3 using an efficient fitting approach.”⁴

Optometrist and Melbourne-based practice owner, Genevieve Hastings believes that presbyopia represents one of the biggest growth opportunities in contact lenses. “With continuing advances in multifocal contact lens technology – better optics and a broader, more sophisticated range available – we can offer patients both excellent vision and lifestyle benefits. That said, these innovative lenses remain underutilised and there’s a genuine opportunity to do more for this group of patients.”

The Complete clariti 1 day Portfolio

The full family of clariti 1 day lenses – sphere, toric, and multifocal – offers all-day comfort¹⁴ and features easy handling¹⁷ and high oxygen transmissibility,^‡18,19,20 allowing for 100% corneal oxygen consumption to help maintain ocular health during daily wear.

Visit: coopervision.net.au or www.coopervision.net.nz

Footnotes

* Combination of 2021 market research based on global volume data and internal estimates.

† Based on Rx option combinations (sphere, cylinder, axis & add) manufactured, across all soft lenses in sphere, toric and multifocal (including made to order), in SiHy and hydrogel from 4 main manufacturers. Includes 1 Day, 2 weekly, and monthly disposable contact lenses. Cosmetic & Photochromatic contact lenses not included. Multiple base curve variants not included.

‡ Based on manufacturers published data (up to 3X sphere and multifocal and up to 2X toric).

• When using the fitting guide or OptiExpert. Fit success 98% MyDay multifocal and 100% clariti 1 day multifocal with two pairs or fewer.

References

1. CVI data on file, 2024.
2. CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti 1 day multifocal 3 Add with a rating of 88 out of 100; n=90 habitual MFCL wearers.
3. CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti 1 day multifocal 3 Add; with a rating of 93 out of 100; n=90 habitual MFCL wearers.
4. CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti 1 day multifocal 3 Add; n=90.
5. Fricke TR, Tahhan N, Resnikoff S, et al. Global prevalence of presbyopia and vision impairment from uncorrected presbyopia: A Systematic review, meta-analysis, and modelling Ophthalmology. 2018;125(10):1432–1449. doi: 10.1016/j.ophtha.2018.04.013.
6. CooperVision data on file. Global multifocal research, 2021.
7. CVI data on file, 2023. Industry reports and internal estimates based on Tyler’s Quarterly, 12/2022.
8. CVI data on file, 2024. CVI data on file, 2022. Prospective, crossover, bilateral, subject masked, daily wear, dispensing study (4 clinical sites in U.S.) (n=58 habitual soft MFCL wearers).
9. CVI data on file, 2019. Prospective, bilateral, subject-masked dispensing study with clariti 1 day multifocal. N=48 habitual soft MFCL wearers at 2 sites in North America. *At baseline approximately 5 mins after lens insertion.
10. CooperVision data on file, 2019. clariti 1 day Wearer experience survey conducted online in US, n=298: sphere, toric or multifocal; habitual FRP, DD, and new wearers who purchased clariti 1 day; strongly or somewhat agree.
11. Orsborn G, Dumbleton K. Eye care professionals’ perceptions of the benefits of daily disposable silicone hydrogel contact lenses, contact lens and anterior eye; 42 (2019) 4:373–379. CVI data on file, 2018. Survey results of ECPs in US, UK and Japan, n=300.
12. CVI data on file 2024. Based on prescription option combinations (sph and add) available across all daily disposable multifocal soft lenses from CVI, JJV, B+L and Alcon in USA Feb 2024.
13. CVI data on file, 2024. CVI data on file, 2022. Prospective, crossover, bilateral, subject masked, daily wear, dispensing study (4 clinical sites in U.S.) (n=58 habitual soft MFCL wearers)
14. CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti 1 day multifocal 3 Add; n=90 habitual MFCL wearers.
15. CooperVision data on file, 2020. Kubic online survey of eye care professionals (US, UK, Japan); n=477.
16. CVI data on file, 2026.
17. CVI data on file 2022. Verve online brand survey with ECPs who recommend somofilcon A for new wearers in US, Spain, Italy, UK and Korea. n=249 (89% strongly agree/agree).
18. Brennan NA. Beyond flux: Total corneal oxygen consumption as an index of corneal oxygenation during contact lens wear. Optom Vis Sci. 2005;82(6):467-472. doi: 10.1097/01.opx.0000168560.10861.ae.
19. Sulley A, Dumbleton K. Silicone hydrogel daily disposable benefits: The evidence. CLAE. 2020 Jun;43(3):298-307. doi: 10.1016/j.clae.2020.02.001.
20. Lumb E, Symons A. Comparison of Dk/t values of daily disposable soft toric contact lenses using high resolution thickness profiling. BCLA Poster presentation at NCC 2016.